Weighted Average Number of Shares Outstanding, Diluted of RIGEL PHARMACEUTICALS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2010 to Q3 2025.
  • Rigel Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 19.2M shares, a 8.55% increase year-over-year.
  • Rigel Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 17.7M shares, a 1.64% increase from 2023.
  • Rigel Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 17.4M shares, a 2.07% increase from 2022.
  • Rigel Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17M shares, a 90% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 19.2M +1.51M +8.55% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 18.2M +613K +3.49% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 18.2M +649K +3.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 17.7M +286K +1.64% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-04
Q3 2024 17.6M +212K +1.22% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 17.5M +193K +1.11% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 17.5M -156M -89.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 17.4M +352K +2.07% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-04
Q3 2023 17.4M -155M -89.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 17.4M -155M -89.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 174M +1.79M +1.04% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 17M -153M -90% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-04
Q3 2022 173M +1.95M +1.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 172M +1.96M +1.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 172M -4.3M -2.44% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 170M +1.45M +0.86% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 171M +1.95M +1.16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 170M +1.62M +0.96% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 176M +7.5M +4.45% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 169M +514K +0.31% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-02
Q3 2020 169M +1.32M +0.79% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 169M +1.38M +0.83% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 169M +1.4M +0.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 169M +908K +0.54% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 168M +1.15M +0.69% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-02
Q2 2019 167M +5.61M +3.48% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-02
Q1 2019 167M +20.1M +13.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-02
Q4 2018 168M +23.4M +16.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 166M +41.8M +33.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 162M +39.1M +31.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 147M +33.5M +29.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 144M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 125M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 123M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 114M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2012 75M +11.6M +18.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 71.6M +410K +0.58% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-06
Q2 2012 71.5M +13.2M +22.6% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 71.4M +19.1M +36.6% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-01
Q4 2011 63.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-04
Q3 2011 71.2M +18.5M +35% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 58.3M +5.76M +11% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 52.3M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q3 2010 52.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 52.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02

RIGEL PHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 17.7M +286K +1.64% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 17.4M +352K +2.07% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 17M -153M -90% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-04
2021 170M +1.74M +1.03% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 169M +1.35M +0.81% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 167M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2014 87.7M +374K +0.43% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-03
2013 87.3M +12.3M +16.4% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-03
2012 75M +11.6M +18.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-03
2011 63.3M +10.8M +20.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 52.6M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.